Aviva PLC
11 October 2005
News release
11 October 2005
AVIVA UPDATE ON RAC INTEGRATION
Lex Vehicle Leasing
Aviva plc ('Aviva') announces that HBOS plc ('HBOS'), its 50:50 joint venture
partner in Lex Vehicle Leasing Limited ('LVL'), has exercised an option under
the JV agreement which will lead to Aviva's disposal of its stake in LVL.
Aviva acquired the 50% stake in LVL as part of its acquisition of RAC earlier
this year, and was aware of HBOS's rights at the time the acquisition was made.
This change of control triggered HBOS's option.
Aviva and HBOS will now enter into discussions to agree a fair market value for
LVL that may or may not lead to the sale of Aviva's interest in the JV to HBOS.
Aviva's sale of its stake in the LVL joint venture will have no impact on the
cost savings Aviva stated it would achieve as a result of integrating the RAC
business into Norwich Union.
Cost savings target to be exceeded
Aviva confirms that it will exceed the cost savings target of £80 million per
annum forecast at the time of the acquisition and now expects to achieve savings
of £100 million per annum in 2006.
Aviva will present full details and further news of developments in its general
insurance business in a seminar for investors and analysts on 18 October at Park
Royal, London. Speakers will include Patrick Snowball, executive director of
Aviva with responsibility for the group's general insurance portfolio, Andrew
Moss, group finance director of Aviva, Mark Hodges, managing director of Norwich
Union General Insurance and Simon Machell, managing director of RAC.
- ends -
Enquiries:
Media
Rob Bailhache, Financial Dynamics +44 (0)20 7269 7200
Analysts
Charles Barrows, investor relations director +44 (0)20 7662 8115
Nicole Marques, investor relations manager +44 (0)20 7662 8302
Notes to editors:
• LVL is a 50:50 joint venture between RAC and HBOS. LVL provides
vehicle leasing, supply, management, maintenance and incident support for
companies who outsource the day-to-day operations of their fleets. In 2004 LVL
contributed £23 million of RAC's pre-tax earnings* of £102 million (*EBITA
before group overheads and exceptional items).
• Details of the Aviva general insurance seminar for investors and
analysts are as follow:
Date: Tuesday, 18 October 2005
Start: 0800 hrs for 0900 hrs (UK time)
End: 1200 hrs (UK time) followed by lunch
Venue: Solus House, Park Royal, London
Contact: jane.sibley@aviva.com or call +44 (0)20 7662 1189
• Aviva is the world's sixth-largest insurance group based on gross
world-wide premiums and market capitalisation (at 31 December 2004); it is one
of the leading providers of life and pensions in Europe and has substantial
businesses in other markets around the world.
• Aviva's main activities are long-term savings, fund management and
general insurance, with world-wide total income of £40 billion and assets under
management of £280 billion at 31 December 2004.
• The Aviva media centre at www.aviva.com/media includes images, company
and product information and a news release archive.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.